AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $135,000 | -28.9% | 17,922 | -5.1% | 0.00% | -33.3% |
Q2 2022 | $190,000 | -22.8% | 18,882 | -5.0% | 0.01% | 0.0% |
Q1 2022 | $246,000 | -67.8% | 19,878 | -40.6% | 0.01% | -64.7% |
Q4 2021 | $765,000 | +3.0% | 33,454 | -0.4% | 0.02% | +6.2% |
Q3 2021 | $743,000 | +83.5% | 33,593 | +7.4% | 0.02% | +77.8% |
Q2 2021 | $405,000 | +3.6% | 31,264 | +3.7% | 0.01% | 0.0% |
Q1 2021 | $391,000 | -6.5% | 30,142 | -0.2% | 0.01% | +12.5% |
Q4 2020 | $418,000 | +40.7% | 30,209 | +49.8% | 0.01% | 0.0% |
Q3 2020 | $297,000 | – | 20,170 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |